Jumpei Taniguchi

15PUBLICATIONS
15CO-AUTHORS
Epidemiological modellingEnvironmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 11, 2026
Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-right-to-reply.

|May 15, 2026
Response to the Letter "Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study".

|Mar 04, 2026
Cost-effectiveness analysis of immune checkpoint inhibitors versus platinum-based doublet chemotherapy in the first-line treatment of advanced non-small-cell lung cancer with High PD-L1 expression in Japan.

Chanon Nusawat, So Sato, Jumpei Taniguchi

|Mar 03, 2026
Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study.

Jumpei Taniguchi, Shotaro Aso, Hideo Yasunaga

|Feb 22, 2026
Risk of injury associated with the sedative potential of second-generation antihistamines: A nationwide retrospective cohort study.

Jumpei Taniguchi, Shotaro Aso, So Sato

|Oct 08, 2025
Mortality after broad- versus narrow-spectrum antibiotic treatment for patients with nursing and healthcare-associated pneumonia: A nationwide retrospective cohort study.

Jumpei Taniguchi, Shotaro Aso, Hiroki Matsui

Pageof 3

Frequent Collaborators

3 joint publications

Shotaro Aso

3 joint publications

Hideo Yasunaga

2 joint publications

So Sato

1 joint publications

Hitoshi Sugawara